Dolutegravir Impurity 8 | CAS 1916490-96-4 - Request Quote
Dolutegravir Impurity 8
| SZ CAT No: | SZ-D052019 |
| CAS No | 1916490-96-4 |
| Mol.F. | C14H9F4N |
| Mol.Wt. | 267.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dolutegravir Impurity 8 is chemically N-(2,4-Difluorobenzyl)-1-(2,4-difluorophenyl)methanimine. Dolutegravir Impurity 8 is supplied with detailed characterization data compliant with regulatory guideline. Dolutegravir Impurity 8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dolutegravir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1916490-96-4
Purchase 1916490-96-4
Order 1916490-96-4
Enquire 1916490-96-4
price of 1916490-96-4
1916490-96-4 Supplier
1916490-96-4 Manufacturer
1916490-96-4 Exporter
buy high quality Dolutegravir Impurity 8
Purchase Dolutegravir Impurity 8
Dolutegravir Impurity 8 suppliers
Dolutegravir Impurity 8 manufacturers
Dolutegravir Impurity 8 price
Order Dolutegravir Impurity 8
Enquire Dolutegravir Impurity 8
Dolutegravir Impurity 8 cost
Dolutegravir Impurity 8 Supplier
Dolutegravir Impurity 8 Distributor
Dolutegravir Impurity 8 for Method Validation
Dolutegravir Reference Standard
Dolutegravir Impurity 8 for ANDA Filing
Dolutegravir Impurity 8 for Forced Degradation Studies
Dolutegravir Impurity 8 Identification Standards
Dolutegravir Impurity 8 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.